PCPAX
Price
$22.70
Change
-$0.02 (-0.09%)
Updated
Aug 15 closing price
Net Assets
766.29M
VVIAX
Price
$70.31
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

PCPAX vs VVIAX

Header iconPCPAX vs VVIAX Comparison
Open Charts PCPAX vs VVIAXBanner chart's image
PACE Large Co Value Equity A
Price$22.70
Change-$0.02 (-0.09%)
VolumeN/A
Net Assets766.29M
Vanguard Value Index Adm
Price$70.31
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
PCPAX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PCPAX vs. VVIAX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCPAX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 196B vs. PCPAX (766M). VVIAX pays higher dividends than PCPAX: VVIAX (2.18) vs PCPAX (1.37). PCPAX was incepted earlier than VVIAX: PCPAX (25 years) vs VVIAX (25 years). PCPAX (1.14) is less costly to investors than VVIAX (0.05). PCPAX is a more actively managed with annual turnover of: 43.00 vs. VVIAX (9.00). PCPAX has a lower initial minimum investment than VVIAX: PCPAX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.91 vs. PCPAX (7.01). VVIAX return over 5 years is better than : 68.54 vs. PCPAX (30.34).
PCPAXVVIAXPCPAX / VVIAX
Total Expense Ratio1.140.052,280%
Annual Report Gross Expense Ratio1.140.052,280%
Fund Existence25 years25 years-
Gain YTD11.8236.517181%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets766M196B0%
Annual Yield % from dividends1.372.1863%
Returns for 1 year7.017.9189%
Returns for 3 years9.6825.9337%
Returns for 5 years30.3468.5444%
Returns for 10 years9.94114.619%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPIX1.930.01
+0.52%
ESSA Pharma
KTTA0.70N/A
N/A
Pasithea Therapeutics Corp
MANH214.79-0.41
-0.19%
Manhattan Associates
NRIM86.31-1.03
-1.18%
Northrim BanCorp
NBTB42.13-0.95
-2.21%
NBT Bancorp